Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IEP vs MCT for Psychosis in Schizophrenia
NCT03955549Phase 3Completed
- Sponsor
- Al Agiad Psychiatry Hospital
- Start
- May 2019
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (3 arms), sponsored by Al Agiad Psychiatry Hospital. Primary endpoints: Positive and Negative Syndrome Scale at Week 8, Psychotic Symptom Rating Scale at Week 8 and 3 more. Started May 2019; status: completed.
Beyond the preview
Go deeper on NCT03955549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03955549.